Ian McFadden

Ian McFadden is a Medical Director in Oncology Medical Affairs at Amgen, where they lead the US Medical Affairs strategy for Multiple Myeloma. They have a robust academic background with a Ph.D. in Interdisciplinary Materials Science, Nanotechnology, Cancer Biology, and Biomedical Engineering from Vanderbilt University. Ian's professional experience includes roles at Vanderbilt University, Invitrogen, and Monolythix, where they developed expertise in scientific communication and drug delivery to solid tumors. Their career at Amgen has progressed from Manager to Medical Director, focusing on evidence generation, clinical trials oversight, and cross-functional team leadership in the oncology sector. Ian is committed to addressing complex scientific problems and effectively communicating with diverse audiences.